Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 576

1.

TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific Features.

Simon S, Wu Z, Cruard J, Vignard V, Fortun A, Khammari A, Dreno B, Lang F, Rulli SJ, Labarriere N.

Front Immunol. 2018 Aug 30;9:1962. doi: 10.3389/fimmu.2018.01962. eCollection 2018.

PMID:
30214446
2.

Decreased photosensitivity to UVA on vemurafenib combined with cobimetinib.

Frenard C, Dutartre H, Boisrobert A, Khammari A, Dreno B.

J Eur Acad Dermatol Venereol. 2018 Sep 10. doi: 10.1111/jdv.15239. [Epub ahead of print]

PMID:
30198584
3.

Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600-Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials.

Hauschild A, Larkin J, Ribas A, Dréno B, Flaherty KT, Ascierto PA, Lewis KD, McKenna E, Zhu Q, Mun Y, McArthur GA.

JAMA Oncol. 2018 Aug 2. doi: 10.1001/jamaoncol.2018.2668. [Epub ahead of print]

PMID:
30073321
4.

Autologous graft-versus-host disease with combined immune checkpoint blockade.

Kofler L, Dréno B, Röcken M.

Eur J Cancer. 2018 Sep;101:275-277. doi: 10.1016/j.ejca.2018.05.016. Epub 2018 Jul 13. No abstract available.

PMID:
30017386
5.

Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifarotene.

Aubert J, Piwnica D, Bertino B, Blanchet-Réthoré S, Carlavan I, Déret S, Dreno B, Gamboa B, Jomard A, Luzy AP, Mauvais P, Mounier C, Pascau J, Pelisson I, Portal T, Rivier M, Rossio P, Thoreau E, Vial E, Voegel JJ.

Br J Dermatol. 2018 Aug;179(2):442-456. doi: 10.1111/bjd.16719. Epub 2018 Jul 4.

PMID:
29974453
6.

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.

Dreno B, Thompson JF, Smithers BM, Santinami M, Jouary T, Gutzmer R, Levchenko E, Rutkowski P, Grob JJ, Korovin S, Drucis K, Grange F, Machet L, Hersey P, Krajsova I, Testori A, Conry R, Guillot B, Kruit WHJ, Demidov L, Thompson JA, Bondarenko I, Jaroszek J, Puig S, Cinat G, Hauschild A, Goeman JJ, van Houwelingen HC, Ulloa-Montoya F, Callegaro A, Dizier B, Spiessens B, Debois M, Brichard VG, Louahed J, Therasse P, Debruyne C, Kirkwood JM.

Lancet Oncol. 2018 Jul;19(7):916-929. doi: 10.1016/S1470-2045(18)30254-7. Epub 2018 Jun 13.

PMID:
29908991
7.

Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates.

Dréno B, Pécastaings S, Corvec S, Veraldi S, Khammari A, Roques C.

J Eur Acad Dermatol Venereol. 2018 Jun;32 Suppl 2:5-14. doi: 10.1111/jdv.15043. Review.

PMID:
29894579
8.

Characterisation of Cutibacterium acnes phylotypes in acne and in vivo exploratory evaluation of Myrtacine®.

Pécastaings S, Roques C, Nocera T, Peraud C, Mengeaud V, Khammari A, Dréno B.

J Eur Acad Dermatol Venereol. 2018 Jun;32 Suppl 2:15-23. doi: 10.1111/jdv.15042.

PMID:
29894577
9.

Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy.

Herbreteau G, Vallée A, Knol AC, Théoleyre S, Quéreux G, Varey E, Khammari A, Dréno B, Denis MG.

Oncotarget. 2018 May 18;9(38):25265-25276. doi: 10.18632/oncotarget.25404. eCollection 2018 May 18.

10.

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.

Saint-Jean M, Knol AC, Volteau C, Quéreux G, Peuvrel L, Brocard A, Pandolfino MC, Saiagh S, Nguyen JM, Bedane C, Basset-Seguin N, Khammari A, Dréno B.

J Immunol Res. 2018 Mar 19;2018:3530148. doi: 10.1155/2018/3530148. eCollection 2018.

11.

Ipilimumab more and more discussed: urgent need for predictive markers of response.

Dréno B.

J Eur Acad Dermatol Venereol. 2018 Jun;32(6):849. doi: 10.1111/jdv.15018. No abstract available.

PMID:
29706000
12.

Atrophic scar formation in patients with acne involves long-acting immune responses with plasma cells and alteration of sebaceous glands.

Carlavan I, Bertino B, Rivier M, Martel P, Bourdes V, Motte M, Déret S, Reiniche P, Menigot C, Khammari A, Dreno B, Fogel P, Voegel JJ.

Br J Dermatol. 2018 Apr 16. doi: 10.1111/bjd.16680. [Epub ahead of print]

PMID:
29663317
13.

Use of Smartphones for Early Detection of Melanoma: Systematic Review.

Rat C, Hild S, Rault Sérandour J, Gaultier A, Quereux G, Dreno B, Nguyen JM.

J Med Internet Res. 2018 Apr 13;20(4):e135. doi: 10.2196/jmir.9392. Review.

14.

Acne and nutrition: hypotheses, myths and facts.

Claudel JP, Auffret N, Leccia MT, Poli F, Dréno B.

J Eur Acad Dermatol Venereol. 2018 Apr 6. doi: 10.1111/jdv.14998. [Epub ahead of print] Review.

PMID:
29633388
15.
16.

Cutibacterium acnes molecular typing: time to standardize the method.

Dagnelie MA, Khammari A, Dréno B, Corvec S.

Clin Microbiol Infect. 2018 Mar 12. pii: S1198-743X(18)30216-7. doi: 10.1016/j.cmi.2018.03.010. [Epub ahead of print] Review.

PMID:
29544912
17.

TOXICAN: a guide for grading dermatological adverse events of cancer treatments.

Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments.

Support Care Cancer. 2018 Aug;26(8):2871-2877. doi: 10.1007/s00520-018-4153-x. Epub 2018 Mar 12.

PMID:
29532244
18.

Isotretinoin treatment and peanut allergy: a new case report and review of the literature.

Paugam C, Saint-Jean M, Colas L, Bernier C, Dréno B.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):e341-e343. doi: 10.1111/jdv.14916. Epub 2018 Mar 26. No abstract available.

PMID:
29512201
19.

Validation of 3D skin imaging for objective repeatable quantification of severity of atrophic acne scarring.

Petit L, Zugaj D, Bettoli V, Dreno B, Kang S, Tan J, Torres V, Layton AM, Martel P.

Skin Res Technol. 2018 Mar 6. doi: 10.1111/srt.12464. [Epub ahead of print]

PMID:
29512189
20.

PD-L1 expression by tumor cell lines: A predictive marker in melanoma.

Knol AC, Nguyen JM, Pandolfino MC, Denis MG, Khammari A, Dréno B.

Exp Dermatol. 2018 Jun;27(6):647-655. doi: 10.1111/exd.13526.

PMID:
29505109
21.

Why We Should Focus on Melanoma-Targeted Screening Strategies.

Rat C, Dreno B, Nguyen JM.

Dermatology. 2017;233(6):480-481. doi: 10.1159/000487080. Epub 2018 Mar 2. No abstract available.

22.

[Guide to university hospital careers in dermatology. The GRENT (Graines Engrais Tuteurs - Seed Fertilizer Plant stick) Program].

Gaudy-Marqueste C, Samimi M, Soria A, Aractingi S, Bodemer C, Chosidow O, Cribier B, Lacour JP, Paul C, Richard MA, Beylot-Barry M, Dreno B.

Ann Dermatol Venereol. 2018 Mar;145(3):200-209. doi: 10.1016/j.annder.2017.11.010. Epub 2018 Feb 12. French. No abstract available.

PMID:
29449018
23.

Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAFV600 mutation-positive melanoma.

Dréno B, Ascierto PA, Atkinson V, Liszkay G, Maio M, Mandalà M, Demidov L, Stroyakovskiy D, Thomas L, de la Cruz-Merino L, Dutriaux C, Garbe C, Bartley K, Karagiannis T, Chang I, Rooney I, Koralek DO, Larkin J, McArthur GA, Ribas A.

Br J Cancer. 2018 Mar 20;118(6):777-784. doi: 10.1038/bjc.2017.488. Epub 2018 Feb 13.

24.

Exogenous human herpesvirus 6 reinfection after tumor-infiltrating T-lymphocyte therapy.

Filippova A, Charles J, Epaulard O, Germi R, Persoons V, Templier I, Leccia MT, Dreno B, Malova I, Morand P, Lupo J.

Cytotherapy. 2018 Apr;20(4):521-523. doi: 10.1016/j.jcyt.2017.12.006. Epub 2018 Feb 9.

PMID:
29434005
25.

Variation in the diagnosis and clinical management of lentigo maligna across Europe: a survey study among European Association of Dermatologists and Venereologists members.

Tio D, Prinsen CAC, Dréno B, Hoekzema R, Augustin M, van Montfrans C.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1476-1484. doi: 10.1111/jdv.14850. Epub 2018 Mar 30.

PMID:
29419913
26.

Oral retinoids and depression: reply from the authors.

Le Moigne M, Fournier JP, Victorri-Vigneau C, Dréno B.

Br J Dermatol. 2018 May;178(5):1224. doi: 10.1111/bjd.16429. Epub 2018 Apr 17. No abstract available.

PMID:
29405256
27.

Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.

Delaunay T, Violland M, Boisgerault N, Dutoit S, Vignard V, Münz C, Gannage M, Dréno B, Vaivode K, Pjanova D, Labarrière N, Wang Y, Chiocca EA, Boeuf FL, Bell JC, Erbs P, Tangy F, Grégoire M, Fonteneau JF.

Oncoimmunology. 2017 Dec 26;7(3):e1407897. doi: 10.1080/2162402X.2017.1407897. eCollection 2018.

PMID:
29399408
28.

The influence of exposome on acne.

Dréno B, Bettoli V, Araviiskaia E, Sanchez Viera M, Bouloc A.

J Eur Acad Dermatol Venereol. 2018 May;32(5):812-819. doi: 10.1111/jdv.14820. Epub 2018 Feb 15.

29.

Confocal microscopy in adult women with acne.

Muguet Guenot L, Vourc'h Jourdain M, Saint-Jean M, Corvec S, Gaultier A, Khammari A, Le Moigne M, Boisrobert A, Paugam C, Dréno B.

Int J Dermatol. 2018 Mar;57(3):278-283. doi: 10.1111/ijd.13910. Epub 2018 Jan 25.

PMID:
29369333
30.

Pyoderma Gangrenosum Under Dabrafenib and Trametinib for Metastatic Melanoma.

Saint-Jean M, Le Moigne M, Daguze J, Bossard C, Peuvrel L, Quéreux G, Dréno B.

Acta Derm Venereol. 2018 Apr 27;98(5):530-531. doi: 10.2340/00015555-2890. No abstract available.

31.

Do Cutibacterium acnes and Staphylococcus aureus define two different types of folliculitis?: Bacteriological study of scalp folliculitis.

Frenard C, Dagnelie MA, Khammari A, Saint-Jean M, Boisrobert A, Corvec S, Dreno B.

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e266-e268. doi: 10.1111/jdv.14793. Epub 2018 Jan 31. No abstract available.

PMID:
29341254
32.

Blood Predictive Biomarkers for Nivolumab in Advanced Melanoma.

Chasseuil E, Saint-Jean M, Chasseuil H, Peuvrel L, Quéreux G, Nguyen JM, Gaultier A, Varey E, Khammari A, Dréno B.

Acta Derm Venereol. 2018 Apr 16;98(4):406-410. doi: 10.2340/00015555-2872.

33.

5-fluorouracil chemowraps for the treatment of multiple actinic keratoses.

Peuvrel L, Saint-Jean M, Quereux G, Brocard A, Le Moigne M, Frénard C, Khammari A, Dreno B.

Eur J Dermatol. 2017 Dec 1;27(6):635-640. doi: 10.1684/ejd.2017.3128.

PMID:
29311041
34.

[On the attractiveness of a university-hospital career in medicine: Obstacles and solutions. The teachers' perspective].

Samimi M, Dreno B, Aractingi S, Beylot-Barry M, Bodemer C, Chosidow O, Cribier B, Lacour JP, Paul C, Richard MA, Gaudy-Marqueste C, Soria A; le Conseil National des universitaires de dermato-vénéréologie, sous-section 50.03.

Ann Dermatol Venereol. 2018 Mar;145(3):196-199. doi: 10.1016/j.annder.2017.10.014. Epub 2017 Dec 11. French. No abstract available.

PMID:
29241631
35.

Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeam™ of expert clinicians.

Richard MA, Amici JM, Basset-Seguin N, Claudel JP, Cribier B, Dreno B.

J Eur Acad Dermatol Venereol. 2018 Mar;32(3):339-346. doi: 10.1111/jdv.14753. Epub 2018 Jan 15. Review.

PMID:
29235161
36.

[What future for dermatology in university hospitals?]

Dréno B, Dupin N.

Ann Dermatol Venereol. 2018 Mar;145(3):157-158. doi: 10.1016/j.annder.2017.11.012. Epub 2017 Dec 8. French. No abstract available.

PMID:
29229191
37.

[Attractiveness of a university hospital career in France: Analysis of perceptions among young dermatologists in 2016].

Soria A, Dreno B, Aractingi S, Beylot-Barry M, Bodemer C, Chosidow O, Cribier B, Lacour JP, Paul C, Richard MA, Gaudy-Marqueste C, Samimi M; les membres du Collège National des universités de dermato-vénéréologie, sous-section 50.03.

Ann Dermatol Venereol. 2018 Mar;145(3):191-196. doi: 10.1016/j.annder.2017.11.003. Epub 2017 Dec 6. French. No abstract available.

PMID:
29223610
38.

Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical Efficacy.

Simon S, Vignard V, Varey E, Parrot T, Knol AC, Khammari A, Gervois N, Lang F, Dreno B, Labarriere N.

Cancer Res. 2017 Dec 15;77(24):7083-7093. doi: 10.1158/0008-5472.CAN-17-1856. Epub 2017 Dec 6.

PMID:
29212853
39.

Circulating tumour DNA: analytical aspects and clinical applications for metastatic melanoma patients.

Herbreteau G, Vallée A, Knol AC, Théoleyre S, Quéreux G, Khammari A, Dréno B, Denis MG.

Ann Biol Clin (Paris). 2017 Dec 1;75(6):619-630. doi: 10.1684/abc.2017.1305. Review.

PMID:
29192597
40.

BRAF mutations might be more common than supposed in vulvar melanomas.

Wylomanski S, Denis MG, Théoleyre S, Bouquin R, Vallée A, Knol AC, Saint-Jean M, Peuvrel L, Dréno B, Quéreux G.

Exp Dermatol. 2018 Feb;27(2):210-213. doi: 10.1111/exd.13472. Epub 2017 Dec 21.

PMID:
29178146
41.

Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signature.

Grob JJ, Mortier L, D'Hondt L, Grange F, Baurain JF, Dréno B, Lebbe C, Robert C, Dompmartin A, Neyns B, Gillet M, Louahed J, Jarnjak S, Lehmann FF.

ESMO Open. 2017 Nov 14;2(5):e000203. doi: 10.1136/esmoopen-2017-000203. eCollection 2017.

42.

AFAST: an adult female acne treatment algorithm for daily clinical practice.

Poli F, Auffret N, Claudel JP, Leccia MT, Dreno B.

Eur J Dermatol. 2018 Feb 1;28(1):101-103. doi: 10.1684/ejd.2017.3157. No abstract available.

PMID:
29171399
43.

Association of programmed death ligand-1 (PD-L1) expression with treatment outcomes in patients with BRAF mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib.

Wongchenko MJ, Ribas A, Dréno B, Ascierto PA, McArthur GA, Gallo JD, Rooney IA, Hsu J, Koeppen H, Yan Y, Larkin J.

Pigment Cell Melanoma Res. 2018 Jul;31(4):516-522. doi: 10.1111/pcmr.12670. Epub 2017 Dec 10.

PMID:
29156488
44.

Decrease in Diversity of Propionibacterium acnes Phylotypes in Patients with Severe Acne on the Back.

Dagnelie MA, Corvec S, Saint-Jean M, Bourdès V, Nguyen JM, Khammari A, Dréno B.

Acta Derm Venereol. 2018 Feb 7;98(2):262-267. doi: 10.2340/00015555-2847.

45.

Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne.

Thiboutot DM, Dréno B, Abanmi A, Alexis AF, Araviiskaia E, Barona Cabal MI, Bettoli V, Casintahan F, Chow S, da Costa A, El Ouazzani T, Goh CL, Gollnick HPM, Gomez M, Hayashi N, Herane MI, Honeyman J, Kang S, Kemeny L, Kubba R, Lambert J, Layton AM, Leyden JJ, López-Estebaranz JL, Noppakun N, Ochsendorf F, Oprica C, Orozco B, Perez M, Piquero-Martin J, See JA, Suh DH, Tan J, Lozada VT, Troielli P, Xiang LF.

J Am Acad Dermatol. 2018 Feb;78(2S1):S1-S23.e1. doi: 10.1016/j.jaad.2017.09.078. Epub 2017 Nov 8.

PMID:
29127053
46.

Prognostic factors for parotid metastasis of cutaneous squamous cell carcinoma of the head and neck.

Bobin C, Ingrand P, Dréno B, Rio E, Malard O, Espitalier F.

Eur Ann Otorhinolaryngol Head Neck Dis. 2018 Apr;135(2):99-103. doi: 10.1016/j.anorl.2017.09.006. Epub 2017 Nov 1.

PMID:
29100720
47.

Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial.

Basset-Séguin N, Hauschild A, Kunstfeld R, Grob J, Dréno B, Mortier L, Ascierto PA, Licitra L, Dutriaux C, Thomas L, Meyer N, Guillot B, Dummer R, Arenberger P, Fife K, Raimundo A, Dika E, Dimier N, Fittipaldo A, Xynos I, Hansson J.

Eur J Cancer. 2017 Nov;86:334-348. doi: 10.1016/j.ejca.2017.08.022. Epub 2017 Nov 5.

48.

Defining the actinic keratosis field: a literature review and discussion.

Figueras Nart I, Cerio R, Dirschka T, Dréno B, Lear JT, Pellacani G, Peris K, Ruiz de Casas A; Progressing Evidence in AK (PEAK) Working Group.

J Eur Acad Dermatol Venereol. 2018 Apr;32(4):544-563. doi: 10.1111/jdv.14652. Epub 2017 Nov 24. Review.

PMID:
29055153
49.

[Cosmetics and topical medications in acne: Where is the boundary?]

Poli F, Claudel JP, Auffret N, Leccia MT, Dréno B.

Ann Dermatol Venereol. 2017 Dec;144(12):768-775. doi: 10.1016/j.annder.2017.08.011. Epub 2017 Oct 6. French.

PMID:
28993016
50.

Supplemental Content

Support Center